Molecular determinants of nuclear receptor-corepressor interaction

Genes and Development

Volumn 13, Issue 24, 1999, Pages 3198-3208

  Perissi, Valentina ^a,b   Staszewski, Lena M ^b   McInerney, Eileen M ^b,c   Kurokawa, Riki ^a,d   Krones, Anna ^b   Rose, David W ^a   Lambert, Mill H ^e   Milburn, Michael V ^e   Glass, Christopher K ^a,c,d   Rosenfeld, Michael G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Division of Chemistry   (United States)

Author keywords

Corepressor coactivator; N CoR; Nuclear receptors; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DNA BINDING; GENE ACTIVATION; GENE MUTATION; GENE REPRESSION; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; DIMERIZATION; HELA CELLS; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PROTEIN STRUCTURE, SECONDARY; RATS; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RETINOID X RECEPTORS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 0033572656     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.24.3198     Document Type: Article

References (55)

1. Barettino, D., M.M. Vivanco Ruiz, and H.G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone. EMBO J. 13: 3039-3049.
2. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: Many actors in search of a plot. Cell 83: 851-857.
3. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375: 377-382.
4. Braunstein, M., A.B. Rose, S.G. Holmes, C.D. Allis, and J.R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes & Dev. 7: 592-604.
5. Brzozowski, A.M., A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J.A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758.
6. Chen, J.D. and R.M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
7. Cohen, R.N., F.E. Wondisford, and A.N. Hollenberg. 1998. Two separate NCoR (Nuclear Receptor Corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol. Endocrinol. 12: 1567-1581.
8. Crawford, P.A., C. Dorn, Y. Sadovsky, and J. Milbrandt. 1998. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18: 2949-2956.
9. Danielian, P.S., R. White, J.A. Lees, and M.G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11: 1025-1030.
10. Darimont, B.D., R.L. Wagner, J.W. Apriletti, M.R. Stallcup, P.J. Kushner, J.D. Baxter, R.J. Fletterick, and K.R. Yamamoto. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes & Dev. 12: 3343-3356.
11. Ding, X.F., C.M. Anderson, H. Ma, H. Hong, R.M. Uht, P.J. Kushner, and M.R. Stallcup. 1998. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities. Mol. Endocrinol. 12: 302-313.
12. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13: 5370-5382.
13. Feng, W., R.C. Ribeiro, R.L. Wagner, H. Nguyen, J.W. Apriletti, R.J. Fletterick, J.D. Baxter, P.J. Kushner, and B.L. West. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280: 1747-1749.
14. Freedman, L.P. 1999. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97: 5-8.
15. Geourjon, C. and G. Deleage. 1994. SOPM: A self-optimized prediction method for protein seondary structure prediction. Protein Eng. 7: 157-164.
16. Heery, D.M., E. Kalkhoven, S. Hoare, and M.G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-736.
17. Heinzel, T., R.M. Lavinsky, T.-M. Mullen, M. Söderström, C.D. Laherty, J. Torchia, W.M. Yang, G. Brard, S.D. Ngo, J.R. Davie et al. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48.
18. Hörlein, A., A. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, Y. Kamei, A. Ryan, M. Söderström, C.K. Glass, and M.G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor is mediated by a nuclear receptor co-repressor, N-CoR. Nature 377: 397-404.
19. Horwitz, K.B., T.A. Jackson, D.L. Bain, J.K. Richer, G.S. Takimoto, and L. Tung. 1996. nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10: 1167-1177.
20. Imhof, M.O. and D.P. McDonnell. 1996. Yeast RSP5 and its human homolog hRPFl potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol. Cell. Biol. 16: 2594-2605.
21. Jackson, T.W., J.K. Richer, D.L. Bain, G.S. Takimoto, L. Tung, and K.B. Horwitz. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11: 693-705.
22. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M.G. Rosenfeld, and C.K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451-454.
23. Lanz, R.B. and S. Rusconi. 1994. A conserved carboxy-terminal subdomain is important for ligand interpretation and transactivation by nuclear receptors. Endocrinology 135: 2183-2195.
24. Lavinsky, R.M., K. Jepsen, T. Heinzel, J. Torchia, T.-M. Mullen, R. Schiff, A.L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch et al. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. 95: 2920-2925.
25. Le Douarin, B., E. vom Baur, C. Zechel, D. Heery, M. Heine, V. Vivat, H. Gronemeyer, R. Losson, and P. Chambon. 1996. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Philos. Trans. R. Soc. Lond. B Biol. Sci. 351: 569-578.
26. Lee, J.W., F. Ryan, J.C. Swaffield, S.A. Johnston, and D.D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374: 91-94.
27. Li, H., C. Leo, D.J. Schroen, and J.D. Chen. 1997. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11: 2025-2037.
28. Lipkin, S.M., T.L. Grider, R.A. Heyman, C.K. Glass, and F.H. Gage. 1996. Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells. J. Virol. 70: 7182-7289.
29. Luo, R.X., A.A. Postigo, and D.C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473.
30. Mangelsdorf, D.J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
31. Mak, H.Y., S. Hoare, P.M. Henttu, and M.G. Parker. 1999. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol. 19: 3895-3903.
32. McInerney, E.M., D.W. Rose, S.E. Flynn, S. Westin, T.-M. Mullen, A. Krones, J. Inostroza, J. Torchia, R.T. Nolte, N. Assa-Munt et al. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes & Dev. 12: 3357-3368.
33. McKenna, N.J., R.B. Lanz, and B.W. O'Malley. 1999. Nuclear receptor coregulators: Cellular and molecular biology. Endocrinol. Rev. 20: 321-344.
34. Nolte, R.T., G.B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, R. Kurokawa, M.G. Rosenfeld, T.M. Willson, C.K. Glass, and M.V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395: 137-143.
35. Norris, J.D., A. Paige, D.J. Christensen, C.Y. Chang, M.R. Huacani, D. Fan, P.T. Hamilton, D.M. Fowlkes, and D.P. McDonnell. 1999. Peptide antagonists of the human estrogen receptor. Science 285: 744-746.
36. Renaud, J.P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689.
37. 3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10: 813-825.
38. Seol, W., M.J. Mahon, Y.-K. Lee, and D.D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10: 1646-1655.
39. Shiau, A.K., D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, D.A. Agard, and G.L. Greene. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927-937.
40. Shibata, H., Z. Nawaz, S.Y. Tsai, B.W. O'Malley, and M.-J. Tsai. 1997. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11: 714-724.
41. Smith, C.L., Z. Nawaz, and B.W. O'Malley. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11: 657-666.
42. Tone, Y., T.N. Collingwood, M. Adams, and V.K. Chatterjee. 1994. Functional analysis of a transactivation domain in the thyroid hormone beta receptor. J. Biol Chem. 269: 31157-31161.
43. Torchia, J., D.W. Rose, J. Inostroza, Y. Kamei, S. Westin, C.K. Glass, and M.G. Rosenfeld. 1997. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387: 677-684.
44. Vegeto, E., G.F. Allan, W.T. Schrader, M.J. Tsai, D.P. McDonnell, and B.W. O'Malley. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69: 703-713.
45. Voegel, J.J., M.J. Heine, M. Tini, V. Vivat, P. Chambon, and H. Gronemeyer. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17: 507-519.
46. Wagner, R.L., J.W. Apriletti, M.E. McGrath, B.L. West, J.D. Baxter, and R.J. Fletterick, 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378: 690-697.
47. Wagner, B.L., J.D. Norris, T.A. Knotts, N.L Weigel, and D.P. McDonnell. 1998. The nuclear corepressors N-CoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol. Cell. Biol. 18: 1369-1378.
48. Westin, S., R. Kurokawa, R.T. Nolte, G.B. Wisely, E.M. McInerney, D.W. Rose, M.V. Milburn, M.G. Rosenfeld, and C.K. Glass. 1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395: 199-202.
49. Wong, C.W. and M.L. Privalsky. 1998. Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol. Cell Biol. 18: 5724-5733.
50. Wurtz, J.M., W. Bourguet, J.P. Renaud, V. Vivat, P. Chambon, D. Moras, and H. Gronemeyer. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3: 87-94.
51. Xu, J., Z. Nawaz, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1996. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc. Natl. Acad. Sci. 93: 12195-12199.
52. Zamir, I., H.P. Harding, G.B. Atkins, A. Horlein, C.K. Glass, M.G. Rosenfeld, and M.A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16: 5458-5465.
53. Zamir, I., J. Zhang, and M.A. Lazar. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes & Dev. 11: 835-846.
54. Zhang, J., M.G. Guenther, R.W. Carthew, and M.A. Lazar. 1998a. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes & Dev. 12: 1775-1780.
55. Zhang, X., M. Jeyakumar, S. Petukhov, and M.K. Bagchi. 1998b. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12: 513-524.